Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography
November 15, 2019 | 10.4244/EIJ-D-19-00618
Showing 1-18 of 18 articles
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ALLEGRA transcatheter heart valve following valve-in-valve intervention October 15, 2019 | 10.4244/EIJ-D-19-00782
Mitral Regurgitation Severity Predicts One Year Therapeutic Benefit of Tendyne Transcatheter Mitral Valve Implantation
May 22, 2019 | 10.4244/EIJ-D-19-00333
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study May 20, 2019 | 10.4244/EIJ-D-18-00947
Interventions for valvular disease
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system February 7, 2019 | 10.4244/EIJ-D-18-00935
Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and BASILICA
September 7, 2018 | 10.4244/EIJ-D-18-00667
Interventions for valvular disease
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve August 3, 2018 | 10.4244/EIJ-D-17-01040
Interventions for valvular disease
Imaging for structural heart procedures: focus on computed tomography September 24, 2017 | 10.4244/EIJ-D-17-00516
Interventions for valvular disease
Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience January 20, 2017 | 10.4244/EIJ-D-16-00299
Interventions for valvular disease
Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability October 10, 2016 | 10.4244/EIJY15M11_09
Interventions for valvular disease
Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 2: geometrical measurements in patients with functional mitral regurgitation October 10, 2016 | 10.4244/EIJY15M11_10
Interventions for valvular disease
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves September 18, 2016 | 10.4244/EIJV12I7A149
Interventions for valvular disease
Calcification of the aortic valve and mitral apparatus: location, quantification and implications for device selection September 18, 2016 | 10.4244/EIJV12SYA4
Coronary interventions
Additive diagnostic value of atherosclerotic plaque characteristics to non-invasive FFR for identification of lesions causing ischaemia: results from a prospective international multicentre trial July 20, 2016 | 10.4244/EIJY15M09_02
Interventions for valvular disease
Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial June 10, 2016 | 10.4244/EIJV12I2A37
Interventions for valvular disease
Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation June 10, 2016 | 10.4244/EIJV12I2A38
Transcatheter mitral valve implantation with Tiara bioprosthesis
September 27, 2014 | 10.4244/EIJV10SUA17
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement
December 27, 2013 | 10.4244/EIJV9I8A156